FDA inspection
Biohaven Pharmaceuticals, Inc: FDA inspection ending Apr 24, 2025
FDA inspection 1269430 · No Action Indicated (NAI) · New Haven, CT
Key facts
| Inspection ID | 1269430 |
|---|---|
| Firm | Biohaven Pharmaceuticals, Inc |
| FEI number | 3010802167 |
| Address | 215 Church St |
| City | New Haven |
| State | CT |
| ZIP | 06510 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Apr 24, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data